Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients

PaperCitations, authors & open-access status

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 251 citations, 2017 year and gold oa status.

251
Citations
2017
Year
gold
OA Status

Related on ScholarIQ

Agnieszka Pozdzik
Author
PLoS ONE
Journal
IgG4-Related and Inflammatory Diseases
Topic
IgG4-Related and Inflammatory Diseases
Topic
Immunodeficiency and Autoimmune Disorders
Topic
Nasolacrimal Duct Obstruction Treatments
Topic
470M+ articles · free account